Genetics and epigenetics of 1q rearrangements in hematological malignancies. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Cytogenetic and Genome Researchearch Année : 2007

Genetics and epigenetics of 1q rearrangements in hematological malignancies.

Résumé

Recently, we and others have described a novel class of chromosome aberrations that involves constitutive heterochromatin on human chromosome 1 (cytogenetic band 1q12). These anomalies are particularly frequent in B cell non-Hodgkins lymphoma (NHL) and multiple myeloma (MM) and, remarkably, almost invariably involve partial or total gain of chromosome 1q (including 1q12 heterochromatin) and the formation of novel heterochromatin/euchromatin junctions. This review discusses the pathological significance of these anomalies in light of i) recent integrated gene expression and array comparative genomic hybridisation (aCGH) profiling in MM and ii) increasing evidence of a key role for heterochromatin in the control of normal and pathological gene silencing.

Domaines

Génétique
Fichier non déposé

Dates et versions

inserm-00335390 , version 1 (29-10-2008)

Identifiants

Citer

A. Fournier, A. Florin, C. Lefebvre, F. Solly, D. Leroux, et al.. Genetics and epigenetics of 1q rearrangements in hematological malignancies.. Cytogenetic and Genome Researchearch, 2007, 118 (2-4), pp.320-7. ⟨10.1159/000108316⟩. ⟨inserm-00335390⟩

Collections

INSERM UGA U823
38 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More